Apremilast in benign chronic pemphigus (Hailey–Hailey disease)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental dermatology 2020-08, Vol.45 (6), p.737-739
Hauptverfasser:	Riquelme‐Mc Loughlin, C., Iranzo, P., Mascaró, J.M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Autoimmune diseases Chronic Disease Dermatology Female Follow-Up Studies Humans Life Sciences & Biomedicine Male Middle Aged Pemphigus Pemphigus, Benign Familial - drug therapy Pemphigus, Benign Familial - genetics Pemphigus, Benign Familial - pathology Phosphodiesterase 4 Inhibitors - administration & dosage Phosphodiesterase 4 Inhibitors - adverse effects Phosphodiesterase 4 Inhibitors - therapeutic use Quality of Life Science & Technology Severity of Illness Index Skin diseases Thalidomide - administration & dosage Thalidomide - adverse effects Thalidomide - analogs & derivatives Thalidomide - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!